ZYRTEC® Clinical Data
Proven consistent relief of bothersome itchy, watery eyes in SAR patients through Week 11
- Improvement in Total Ocular Symptom Score (TOSS) during the first week of treatment*
- Large, multicenter study of 1,255 seasonal allergy patients; most with moderate/severe symptoms based on a 4-point scale (0=none to 3=severe)
Relief continued over the 2-week treatment period*1
- 35% to 62% mean improvement from baseline in ocular scores*
*Randomized, placebo-controlled studies of SAR patients (N=1255). Total ocular symptom score (TOSS) was the sum of the severity scores for itchy eyes and watery eyes; one study also included red eyes. Individual symptom scores were rated on a 4-point scale (0=none to 3=severe).
SAR 1 was 1 week in duration.
Reference: 1. Patel M, Urdaneta E, Franklin K, et al. Cetirizine significantly relieves ocular allergy symptoms in subjects with seasonal allergic rhinitis. Poster Abstract. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Health Division.
Need samples or patient resources?
More clinical data on ZYRTEC®
Here are additional clinical data on the efficacy and tolerability of ZYRTEC®
See the complete family of ZYRTEC® products.